Rosemary Millen

968 total citations
15 papers, 168 citations indexed

About

Rosemary Millen is a scholar working on Oncology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Rosemary Millen has authored 15 papers receiving a total of 168 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Pathology and Forensic Medicine and 4 papers in Genetics. Recurrent topics in Rosemary Millen's work include Chronic Lymphocytic Leukemia Research (4 papers), Lymphoma Diagnosis and Treatment (3 papers) and Thermal Regulation in Medicine (2 papers). Rosemary Millen is often cited by papers focused on Chronic Lymphocytic Leukemia Research (4 papers), Lymphoma Diagnosis and Treatment (3 papers) and Thermal Regulation in Medicine (2 papers). Rosemary Millen collaborates with scholars based in Australia, Netherlands and United States. Rosemary Millen's co-authors include Hans Clevers, Else Driehuis, Robert G. Ramsay, Maurice M.J.M. Zandvliet, Harry Begthel, Maarten H. Geurts, Shienny Sampurno, Sjoerd G. Elias, Jordane Malaterre and Remco de Bree and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Oncogene.

In The Last Decade

Rosemary Millen

15 papers receiving 164 citations

Peers

Rosemary Millen

ONCOL

PRM

PFM

Julia Krzykalla Germany

Rocco Giannicola Italy

Anna Gurevich‐Shapiro Israel

Cristina Pizzimenti Italy

Erik Asmus United States

Charles‐André Philip France

Ziad Thotathil New Zealand

Heike Weidner Germany

Julia Krzykalla Germany

Rosemary Millen

93 ×1.1

ONCOL

54 ×1.1

14 ×0.5

PRM

26 ×0.9

54 ×2.0

PFM

Citations per year, relative to Rosemary Millen Rosemary Millen (= 1×) peers Julia Krzykalla

Countries citing papers authored by Rosemary Millen

Since Specialization

Citations

This map shows the geographic impact of Rosemary Millen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosemary Millen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosemary Millen more than expected).

Fields of papers citing papers by Rosemary Millen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosemary Millen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosemary Millen. The network helps show where Rosemary Millen may publish in the future.

Co-authorship network of co-authors of Rosemary Millen

This figure shows the co-authorship network connecting the top 25 collaborators of Rosemary Millen. A scholar is included among the top collaborators of Rosemary Millen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosemary Millen. Rosemary Millen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Kater, Arnon P., Barbara Eichhorst, Carolyn Owen, et al.. (2024). Long‐term immune changes in patients with relapsed/refractory chronic lymphocytic leukemia following treatment with venetoclax plus rituximab. HemaSphere. 8(8). e146–e146. 1 indexed citations

Boretto, Matteo, Maarten H. Geurts, Shashank Gandhi, et al.. (2024). Epidermal growth factor receptor (EGFR) is a target of the tumor-suppressor E3 ligase FBXW7. Proceedings of the National Academy of Sciences. 121(12). e2309902121–e2309902121. 9 indexed citations

Kater, Arnon P., Rosemary Harrup, Thomas J. Kipps, et al.. (2023). MURANO: Final 7 year follow up and retreatment analysis in venetoclax‐rituximab (VenR)‐treated patients with relapsed/refractory chronic lymphocytic leukemia (R/R CLL). Hematological Oncology. 41(S2). 239–242. 8 indexed citations

Millen, Rosemary, Harry Begthel, Maurice M.J.M. Zandvliet, et al.. (2023). Patient-derived head and neck cancer organoids allow treatment stratification and serve as a tool for biomarker validation and identification. Med. 4(5). 290–310.e12. 56 indexed citations

Kater, Arnon P., Rosemary Harrup, Thomas J. Kipps, et al.. (2023). S201: FINAL 7-YEAR FOLLOW UP AND RETREATMENT SUBSTUDY ANALYSIS OF MURANO: VENETOCLAX-RITUXIMAB (VENR)-TREATED PATIENTS WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (R/R CLL). HemaSphere. 7(S3). e492813f–e492813f. 11 indexed citations

Sampurno, Shienny, Michael P. Flood, Rosemary Millen, et al.. (2022). Effect of Surgical Humidification on Inflammation and Peritoneal Trauma in Colorectal Cancer Surgery: A Randomized Controlled Trial. Annals of Surgical Oncology. 29(12). 7911–7920. 3 indexed citations

Kater, Arnon P., Barbara Eichhorst, Carolyn Owen, et al.. (2022). Long-Term Host Immune Changes Following Treatment with Venetoclax Plus Rituximab in Relapsed/Refractory Chronic Lymphocytic Leukemia. Blood. 140(Supplement 1). 7010–7012. 1 indexed citations

Putker, Marrit, Rosemary Millen, René Overmeer, et al.. (2021). Medium-Throughput Drug- and Radiotherapy Screening Assay using Patient-Derived Organoids. Journal of Visualized Experiments. 12 indexed citations

Millen, Rosemary, Shona Hendry, Vignesh Narasimhan, et al.. (2020). CD8⁺ tumor‐infiltrating lymphocytes within the primary tumor of patients with synchronous de novo metastatic colorectal carcinoma do not track with survival. Clinical & Translational Immunology. 9(7). e1155–e1155. 6 indexed citations

10.

Tolstrup, Martin, Kumar Visvanathan, Ian Woolley, et al.. (2018). Levels of regulatory B cells do not predict serological responses to hepatitis B vaccine. Human Vaccines & Immunotherapeutics. 14(6). 1483–1488. 6 indexed citations

11.

Hiller, Jonathan G., Shienny Sampurno, Rosemary Millen, et al.. (2017). Impact of celecoxib on inflammation during cancer surgery: a randomized clinical trial. Canadian Journal of Anesthesia/Journal canadien d anesthésie. 64(5). 497–505. 10 indexed citations

12.

Sampurno, Shienny, Jordane Malaterre, Rosemary Millen, et al.. (2017). Experimental study of delivery of humidified-warm carbon dioxide during open abdominal surgery. British journal of surgery. 105(5). 597–605. 9 indexed citations

13.

Millen, Rosemary, Jordane Malaterre, Ryan Cross, et al.. (2016). Immunomodulation by MYB is associated with tumor relapse in patients with early stage colorectal cancer. OncoImmunology. 5(7). e1149667–e1149667. 15 indexed citations

14.

Malaterre, Jordane, Lloyd Pereira, Tracy L. Putoczki, et al.. (2015). Intestinal-specific activatable Myb initiates colon tumorigenesis in mice. Oncogene. 35(19). 2475–2484. 19 indexed citations

15.

Holmes, Jacinta A., Narelle Skinner, M Congiu, et al.. (2015). P0702 : CC IL28B Genotype is associated with high liver necroinflammation and increased expression of TH1 cytokines (CYK) and chemokines (CHK), but also higher TH2 CYK which may drive low ISG expression. Journal of Hepatology. 62. S586–S586. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact